Myelodysplastic syndrome (MDS) as a late stage of subclinical hemophagocytic lymphohistiocytosis (HLH): A putative role for Leptospira infection. A hypothesis

Acta Microbiologica et Immunologica Hungarica

Volumn 57, Issue 3, 2010, Pages 181-189

  Niller, H H ^a  

^a UNIVERSITY HOSPITAL REGENSBURG   (Germany)

Author keywords

acute myeloid leukemia (AML); autoimmune disease; epigenetic; Epstein Barr virus (EBV); hematology; immunomodulation; malignancy; microbiology

Indexed keywords

CORTICOSTEROID; ETOPOSIDE; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; IMMUNOGLOBULIN; IMMUNOGLOBULIN G ANTIBODY;

ANTIBODY TITER; ARTICLE; CYTOGENETICS; DISEASE ACTIVITY; DISEASE COURSE; DISEASE SEVERITY; DRUG MEGADOSE; EPSTEIN BARR VIRUS; HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS; HEPATITIS; HUMAN; IMMUNE RESPONSE; IMMUNOPATHOLOGY; LEPTOSPIRA; LEPTOSPIROSIS; LOW DRUG DOSE; MYELODYSPLASTIC SYNDROME; NONHUMAN; PATHOPHYSIOLOGY; STATISTICAL SIGNIFICANCE;

HUMAN HERPESVIRUS 4; LEPTOSPIRA;

EID: 77957567350     PISSN: 12178950     EISSN: 15882640     Source Type: Journal    
DOI: 10.1556/AMicr.57.2010.3.3     Document Type: Article

References (40)

1. Gupta, A. A., Tyrrell, P., Valani, R., Benseler, S., Abdelhaleem, M., Weitzman, S.: Experience with hemophagocytic lymphohistiocytosis/macrophage activation syndrome at a single institution. J. Pediatr. Hematol. Oncol. 31, 81-84 (2009).
2. Chang, C. S., Wang, C. H., Su, I. J., Chen, Y. C., Shen, M. C.: Hematophagic histiocytosis: A clinicopathologic analysis of 23 cases with special reference to the association with peripheral T-cell lymphoma. J. Formos. Med. Assoc. 93, 421-428 (1994).
3. Imashuku, S., Teramura, T., Tauchi, H., Ishida, Y., Otoh, Y., Sawada, M., Tanaka, H., Watanabe, A., Tabata, Y., Morimoto, A., Hibi, S., Henter, J. I.: Longitudinal follow-up of patients with Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis. Haematologica 89, 183-188 (2004).
4. Abdelkefi, A., Ben Othman, T., Torjman, L., Ladeb, S., Lakhal, A., Belhadj, S., Ayari, S., Cherif, N., Ben Achour, O., Chaker, E., Ben Abdeladhim, A.: Plasmodium falciparum causing hemophagocytic syndrome after allogeneic blood stem cell transplantation. Hematol. J. 5, 449-450 (2004).
5. Satomi, A., Nagai, S., Nagai, T., Niikura, K., Ideura, T., Ogata, H., Akizawa, T.: Effect of plasma exchange on refractory hemophagocytic syndrome complicated with myelodysplastic syndrome. Ther. Apher. 3, 317-319 (1999).
6. Malliah, R. B., Chang, V. T., Choe, J. K.: Infection-associated haemophagocytic syndrome associated with recurrent acute myeloid leukaemia/myelodysplastic syndrome: An autopsy case. J. Clin. Pathol. 60, 431-433 (2007).
7. Fuchs, W. A., Guggenbichler, J. P.: Familial hemophagocytic lymphohistiocytosis (case report). Padiatr. Padol. 22, 67-72 (1987).
8. Yang, C. W., Pan, M. J., Wu, M. S., Chen, Y. M., Tsen, Y. T., Lin, C. L., Wu, C. H., Huang, C. C.: Leptospirosis: An ignored cause of acute renal failure in Taiwan. Am. J. Kidney Dis. 30, 840-845 (1997).
9. Guegan, R., Camadro, J. M., Saint, G., Picardeau, I. M.: Leptospira spp. possess a complete haem biosynthetic pathway and are able to use exogenous haem sources. Mol. Microbiol. 49, 745-754 (2003).
10. Imashuku, S., Teramura, T., Morimoto, A., Hibi, S.: Recent developments in the management of haemophagocytic lymphohistiocytosis. Expert. Opin. Pharmacother. 2, 1437-1448 (2001).
11. Pui, C. H., Ribeiro, R. C., Hancock, M. L., Rivera, G. K., Evans, W. E., Raimondi, S. C., Head, D. R., Behm, F. G., Mahmoud, M. H., Sandlund, J. T., Christ, W. M.: Acute myeloid leukemia in children treated with epipodophyllotoxins for acute lymphoblastic leukemia. N. Engl. J. Med. 325, 1682-1687 (1991).
12. Henter, J. I., Elinder, G., Lubeck, P. O., Ost, A.: Myelodysplastic syndrome following epipodophyllotoxin therapy in familial hemophagocytic lymphohistiocytosis. Pediatr. Hematol. Oncol. 10, 163-168 (1993).
13. Kitazawa, J., Ito, E., Arai, K., Yokoyama, M., Fukayama, M., Imashuku, S.: Secondary acute myelocytic leukemia after successful chemotherapy with etoposide for Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis. Med. Pediatr. Oncol. 37, 153-154 (2001).
14. Seo, Y. I., Park, R., Choi, T. Y., Shin, J. W., Won, J. H., Park, H. S., Lee, N. S., Cho, D.: A case of therapy-related acute monocytic leukemia following low-dose of etoposide treatment for hemophagocytic lymphohistiocytosis. Korean J. Lab Med. 27, 244-247 (2007).
15. Yoshida, Y.: Physician education: Myelodysplastic syndrome. Oncologist 1, 284-287 (1996).
16. Scott, B. L., Deeg, H. J.: Myelodysplastic syndromes. Annu. Rev. Med. 61, 345-358 (2010).
17. Niller, H. H., Wolf, H., Minarovits, J.: Epstein-Barr virus. In: Minarovits, J., Gonczol, E., Valyi-Nagy, T. (eds), Latency Strategies of Herpesviruses. Springer, New York, 2007, pp. 154-191.
18. Matsuda, A., Germing, U., Jinnai, I., Araseki, K., Kuendgen, A., Strupp, C., Iwanaga, M., Miyazaki, Y., Hata, T., Bessho, M., Gattermann, N., Tomonaga, M.: Differences in the distribution of subtypes according to the WHO classification 2008 between Japanese and German patients with refractory anemia according to the FAB classification in myelodysplastic syndromes. Leuk. Res. (2009) doi:10.1016/j.leukres.2009.11.015.
19. Prokocimer, M., Inbal, A., Gelber, M., Shohat, B., Ben Basat, M., Shaklai, M.: Hemophagocytosis simulating malignant histiocytosis: A terminal event of the myelodysplastic syndrome. Acta Haematol. 74, 164-167 (1985).
20. Horn, T. D., Hines, H. C., Farmer, E. R.: Erythrophagocytosis in the skin: Case report. J. Cutan. Pathol. 15, 399-403 (1988).
21. Cohen, A. M., Alexandrova, S., Bessler, H., Mittelman, M., Cycowitz, Z., Djaldetti, M.: Ultrastructural observations on bone marrow cells of 26 patients with myelodysplastic syndromes. Leuk. Lymphoma. 27, 165-172 (1997).
22. Kraus, M. D., Bartlett, N. L., Fleming, M. D., Dorfman, D. M.: Splenic pathology in myelodysplasia: A report of 13 cases with clinical correlation. Am. J. Surg. Pathol. 22, 1255-1266 (1998).
23. Karasuno, T., Teshima, H., Hiraoka, A., Nakamura, H., Masaoka, T.: Successful bone marrow transplantation in an adult patient with reactive hemophagocytic syndrome associated with myelodysplastic syndrome. Int. J. Hematol. 71, 180-183 (2000).
24. Imashuku, S., Kitazawa, K., Ishii, M., Kataoka, S., Asami, K., Ishii, E., Fukushima, K., Sako, M., Matsubayashi, T., Teramura, G. T., Hibi, S.: Bone marrow changes mimicking myelodysplasia in patients with hemophagocytic lymphohistiocytosis. Int. J. Hematol. 72, 353-357 (2000).
25. Wang, S., Degar, B. A., Zieske, A., Shafi, N. Q., Rose, M. G.: Hemophagocytosis exacerbated by G-CSF/GM-CSF treatment in a patient with myelodysplasia. Am. J. Hematol. 77, 391-396 (2004).
26. Ganoza, C. A., Segura, E. R., Swancutt, M. A., Gotuzzo, E., Vinetz, J. M.: Mild, self-resolving acute leptospirosis in an HIV-infected patient in the Peruvian Amazon. Am. J. Trop. Med. Hyg. 73, 67-68 (2005).
27. Antoniadis, A., Papapanagiotou, J.: Serological evidence of human leptospirosis in northern Greece. Zentralbl. Bakteriol. Orig. A. 244, 546-551 (1979).
28. Myers, D. M., Varela-Diaz, V. M.: The occurrence of leptospiral antibodies in rural inhabitants of Argentina. Trop. Geogr. Med. 31, 269-274 (1979).
29. Zamora, J., Riedemann, S., Montecinos, M. I., Cabezas, X.: Serological survey of human leptospirosis in a high risk population in Chile. Rev. Med. Chil. 118, 247-252 (1990).
30. Cermakova, Z., Pliskova, L., Ryskova, O.: Laboratory diagnosis of leptospirosis. Folia Microbiol. (Praha). 50, 345-347 (2005).
31. Ko, A. I., Goarant, C., Picardeau, M.: Leptospira: The dawn of the molecular genetics era for an emerging zoonotic pathogen. Nat. Rev. Microbiol. 7, 736-747 (2009).
32. Ganoza, C. A., Matthias, M. A., Saito, M., Cespedes, M., Gotuzzo, E., Vinetz, J. M.: Asymptomatic renal colonization of humans in the Peruvian Amazon by Leptospira. PLoS. Negl. Trop. Dis. 4, e612 (2010).
33. Chierakul, W., Tientadakul, P., Suputtamongkol, Y., Wuthiekanun, V., Phimda, K., Limpaiboon, R., Opartkiattikul, N., White, N. J., Peacock, S. J., Day, N. P.: Activation of the coagulation cascade in patients with leptospirosis. Clin. Infect. Dis. 46, 254-260 (2008).
34. Pappas, G., Akritidis, N., Christou, L., Mastora, M., Tsianos, E.: Unusual causes of reactive arthritis: Leptospira and Coxiella burnetii. Clin. Rheumatol. 22, 343-346 (2003).
35. Velasco-Castrejon, O., Rivas-Sanchez, B., Espinoza, J., Jimenez, J., Ruiz, E.: Mimic diseases accompanying leptospirosis. Rev. Cubana Med. Trop. 57, 75-76 (2005).
36. de Souza, A. L., Sztajnbok, J., Spichler, A., Carvalho, S. M., de Oliveira, A. C., Seguro, A. C.: Peripheral nerve palsy in a case of leptospirosis. Trans. R. Soc. Trop. Med. Hyg. 100, 701-703 (2006).
37. Velasco-Castrejon, O., Rivas-Sanchez, B., Gutierrez, E., Chavez, L., Duarte, P., Chavarria, S., Rivera-Reyes, H. H.: Leptospira, does it simulate or cause leukemia? Rev. Cubana Med. Trop. 57, 17-24 (2005).
38. Nicolescu, M., Andreescu, N.: May human leptospirosis develop as a chronic infection? Zentralbl. Bakteriol. Mikrobiol. Hyg. A. 257, 531-534 (1984).
39. Ambinder, R. F.: Gammaherpesviruses and "Hit-and-Run" oncogenesis. Am. J. Pathol. 156, 1-3 (2000).
40. Nevels, M., Tauber, B., Spruss, T., Wolf, H., Dobner, T.: "Hit-and-run" transformation by adenovirus oncogenes. J. Virol. 75, 3089-3094 (2001).